Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1218

1.

Appendiceal Perforation due to Migration of a Dental Instrument.

Tsukamoto R, Miyano S, Machida M, Kitabatake T, Fujisawa M, Kojima K.

Case Rep Gastroenterol. 2018 Sep 18;12(3):551-555. doi: 10.1159/000444520. eCollection 2018 Sep-Dec.

2.

Protocol for a comparison study of 1-day (single dose) versus 2-day prophylactic antibiotic administration in Holmium Laser enucleation of the prostate (HoLEP): a randomized controlled trial.

Shigemura K, Yamamichi F, Nishimoto K, Kitagawa K, Fujisawa M.

Version 2. F1000Res. 2019 Feb 6 [revised 2019 Jan 1];8:161. doi: 10.12688/f1000research.17660.2. eCollection 2019.

3.

Editorial Comment to Potential of hyperbaric oxygen in urological diseases.

Shigemura K, Fujisawa M.

Int J Urol. 2019 May 30. doi: 10.1111/iju.14033. [Epub ahead of print] No abstract available.

PMID:
31148221
4.

Importance of interim restorations in the molar region.

Miura S, Fujisawa M, Komine F, Maseki T, Ogawa T, Takebe J, Nara Y.

J Oral Sci. 2019 Jun 18;61(2):195-199. doi: 10.2334/josnusd.19-0102. Epub 2019 May 21.

5.

FEASIBILITY STUDY ON THE FUSION OF PHITS SIMULATIONS AND THE DLNN ALGORITHM FOR A NEW QUANTITATIVE METHOD OF IN-SITU MULTIPLE-CHANNEL DEPTH DISTRIBUTION SPECTROMETRY.

Sakama M, Fujimoto K, Inoue K, Fukushi M, Imajyo Y, Fukuhara T, Matsuura M, Yajima T, Endo M, Fujisawa M, Matsumoto-Kawaguchi E.

Radiat Prot Dosimetry. 2019 Apr 30. pii: ncz093. doi: 10.1093/rpd/ncz093. [Epub ahead of print]

PMID:
31038704
6.

The relationship between the PD-L1 expression of surgically resected and fine-needle aspiration specimens for patients with pancreatic cancer.

Matsumoto K, Ohara T, Fujisawa M, Takaki A, Takahara M, Tanaka N, Kato H, Horiguchi S, Yoshida R, Umeda Y, Fushimi S, Yagi T, Matsukawa A, Okada H.

J Gastroenterol. 2019 Apr 29. doi: 10.1007/s00535-019-01586-6. [Epub ahead of print]

PMID:
31032528
7.

Correction to: Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome.

Fujisawa M, Kato H, Yoshida Y, Usui T, Takata M, Fujimoto M, Wada H, Uchida Y, Kokame K, Matsumoto M, Fujimura Y, Miyata T, Nangaku M.

Clin Exp Nephrol. 2019 Jul;23(7):985. doi: 10.1007/s10157-019-01728-3.

8.

Application of hyaluronic acid/carboxymethyl cellulose membrane for early continence after nerve-sparing robot-assisted radical prostatectomy.

Hinata N, Bando Y, Chiba K, Furukawa J, Harada K, Ishimura T, Nakano Y, Fujisawa M.

BMC Urol. 2019 Apr 23;19(1):25. doi: 10.1186/s12894-019-0458-4.

9.
10.

One-Year Impact of Kidney Transplantation on Cardiac Abnormalities and Blood Pressure in Hemodialysis Patients.

Fujii H, Watanabe S, Kono K, Watanabe K, Goto S, Ishimura T, Fujisawa M, Nishi S.

Ther Apher Dial. 2019 Apr 2. doi: 10.1111/1744-9987.12808. [Epub ahead of print]

PMID:
30941871
11.

Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.

Ueno Y, Takeuchi M, Tamada T, Sofue K, Takahashi S, Kamishima Y, Hinata N, Harada K, Fujisawa M, Murakami T.

Eur Urol. 2019 Jul;76(1):54-56. doi: 10.1016/j.eururo.2019.03.012. Epub 2019 Mar 26.

PMID:
30922688
12.

Correction to: Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry.

Takamatsu H, Yoroidaka T, Fujisawa M, Kobori K, Hanawa M, Yamashita T, Murata R, Ueda M, Nakao S, Matsue K.

Int J Hematol. 2019 Apr;109(4):505. doi: 10.1007/s12185-019-02621-1.

PMID:
30903563
13.

Preclinical Development of a WT1 Oral Cancer Vaccine Using a Bacterial Vector to Treat Castration-Resistant Prostate Cancer.

Kitagawa K, Gonoi R, Tatsumi M, Kadowaki M, Katayama T, Hashii Y, Fujisawa M, Shirakawa T.

Mol Cancer Ther. 2019 May;18(5):980-990. doi: 10.1158/1535-7163.MCT-18-1105. Epub 2019 Mar 1.

PMID:
30824610
14.

External validation of nomograms for prediction of progression-free survival and liver toxicity in patients with advanced renal cell carcinoma treated with pazopanib.

Okamura Y, Hinata N, Terakawa T, Furukawa J, Harada K, Nakano Y, Nakamura I, Inoue T, Ogawa T, Fujisawa M.

Int J Clin Oncol. 2019 Jun;24(6):698-705. doi: 10.1007/s10147-019-01401-5. Epub 2019 Feb 23.

PMID:
30798395
15.

Efficacy of Prophylactic Antimicrobial Administration of Tazobactam/Piperacillin for Radical Cystectomy with Urinary Diversion: A Multicenter Study.

Shigemura K, Tanaka K, Hamasuna R, Ishikawa K, Matsumoto T, Arakawa S, Kiyota H, Yamamoto S, Fujisawa M; Japanese Research Group for Urinary Tract Infection (JRGU).

Urol Int. 2019;102(3):293-298. doi: 10.1159/000496209. Epub 2019 Feb 18.

PMID:
30783034
16.

Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry.

Takamatsu H, Yoroidaka T, Fujisawa M, Kobori K, Hanawa M, Yamashita T, Murata R, Ueda M, Nakao S, Matsue K.

Int J Hematol. 2019 Apr;109(4):377-381. doi: 10.1007/s12185-019-02615-z. Epub 2019 Feb 18. Erratum in: Int J Hematol. 2019 Mar 21;:.

PMID:
30778767
17.

Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice.

Ohkura T, Yoshimura T, Fujisawa M, Ohara T, Marutani R, Usami K, Matsukawa A.

Front Immunol. 2019 Jan 22;10:17. doi: 10.3389/fimmu.2019.00017. eCollection 2019.

18.

Effect of mirabegron on tight junction molecules in primary cultured rat Sertoli cells.

Tanaka M, Chiba K, Okada K, Fujisawa M.

Andrologia. 2019 Jun;51(5):e13241. doi: 10.1111/and.13241. Epub 2019 Jan 31.

PMID:
30706522
19.

Editorial Comment to Updates in endourological management of urolithiasis.

Shigemura K, Fujisawa M.

Int J Urol. 2019 Feb;26(2):183-184. doi: 10.1111/iju.13897. Epub 2019 Jan 18. No abstract available.

PMID:
30659670
20.

Influence of elastic modulus mismatch between dentin and post-and-core on sequential bonding failure.

Teshigawara D, Ino T, Otsuka H, Isogai T, Fujisawa M.

J Prosthodont Res. 2019 Apr;63(2):227-231. doi: 10.1016/j.jpor.2018.12.003. Epub 2019 Jan 14.

PMID:
30651211
21.

SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.

Mesaki K, Yamane M, Sugimoto S, Fujisawa M, Yoshimura T, Kurosaki T, Otani S, Miyoshi S, Oto T, Matsukawa A, Toyooka S.

Surg Today. 2019 May;49(5):443-450. doi: 10.1007/s00595-018-1753-5. Epub 2019 Jan 7.

PMID:
30617600
22.

Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae ST258 isolated from a Japanese patient without a history of foreign travel - a new public health concern in Japan: a case report.

Ainoda Y, Aoki K, Ishii Y, Okuda K, Furukawa H, Manabe R, Sahara T, Nakamura-Uchiyama F, Kurosu H, Ando Y, Fujisawa M, Hoshino H, Arima H, Ohnishi K.

BMC Infect Dis. 2019 Jan 7;19(1):20. doi: 10.1186/s12879-018-3649-9.

23.

Overexpression of SOCS3 mediated by adenovirus vector in mouse and human castration-resistant prostate cancer cells increases the sensitivity to NK cells in vitro and in vivo.

Yoneda T, Kunimura N, Kitagawa K, Fukui Y, Saito H, Narikiyo K, Ishiko M, Otsuki N, Nibu KI, Fujisawa M, Serada S, Naka T, Shirakawa T.

Cancer Gene Ther. 2019 Jan 4. doi: 10.1038/s41417-018-0075-5. [Epub ahead of print]

PMID:
30607005
24.

Clinical Risk Factors for Death Caused by Extended-Spectrum Beta-Lactamase: Producing Bacteria.

Mita Y, Shigemura K, Osawa K, Kitagawa K, Kotaki T, Shirakawa T, Miyara T, Fujisawa M.

Urol Int. 2019;102(2):205-211. doi: 10.1159/000495314. Epub 2019 Jan 2.

PMID:
30602152
25.

Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials.

Kawaguchi T, Suzuki F, Imamura M, Murashima N, Yanase M, Mine T, Fujisawa M, Sato I, Yoshiji H, Okita K, Suzuki K.

Hepatol Res. 2019 Apr;49(4):404-418. doi: 10.1111/hepr.13300. Epub 2019 Feb 1.

PMID:
30589492
26.

Recovery of Spermatogenesis Following Cancer Treatment with Cytotoxic Chemotherapy and Radiotherapy.

Okada K, Fujisawa M.

World J Mens Health. 2019 May;37(2):166-174. doi: 10.5534/wjmh.180043. Epub 2018 Nov 27. Review.

27.

Bacteremia complicating urinary tract infection by Pseudomonas aeruginosa: Mortality risk factors.

Kitagawa K, Shigemura K, Yamamichi F, Osawa K, Uda A, Koike C, Tokimatsu I, Shirakawa T, Miyara T, Fujisawa M.

Int J Urol. 2019 Mar;26(3):358-362. doi: 10.1111/iju.13872. Epub 2018 Dec 21.

PMID:
30575137
28.

Total necrosis after sequential treatment with pazopanib followed by nivolumab in a patient with renal cell carcinoma involving the inferior vena cava.

Shiraishi Y, Terakawa T, Jimbo N, Shigemura K, Hinata N, Fujisawa M.

Int J Urol. 2019 Feb;26(2):313-314. doi: 10.1111/iju.13853. Epub 2018 Nov 14. No abstract available.

PMID:
30430647
29.

Periodontitis, periodontal inflammation, and mild cognitive impairment: A 5-year cohort study.

Iwasaki M, Kimura Y, Ogawa H, Yamaga T, Ansai T, Wada T, Sakamoto R, Ishimoto Y, Fujisawa M, Okumiya K, Miyazaki H, Matsubayashi K.

J Periodontal Res. 2019 Jun;54(3):233-240. doi: 10.1111/jre.12623. Epub 2018 Oct 21.

PMID:
30345659
30.

Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan.

Harada K, Nozawa M, Uemura M, Tatsugami K, Osawa T, Yamana K, Kimura G, Fujisawa M, Nonomura N, Eto M, Shinohara N, Tomita Y, Kondo Y, Ochi K, Anazawa Y, Uemura H.

Int J Urol. 2019 Feb;26(2):202-210. doi: 10.1111/iju.13830. Epub 2018 Oct 21.

PMID:
30345560
31.

Photo-induced semimetallic states realised in electron-hole coupled insulators.

Okazaki K, Ogawa Y, Suzuki T, Yamamoto T, Someya T, Michimae S, Watanabe M, Lu Y, Nohara M, Takagi H, Katayama N, Sawa H, Fujisawa M, Kanai T, Ishii N, Itatani J, Mizokawa T, Shin S.

Nat Commun. 2018 Oct 17;9(1):4322. doi: 10.1038/s41467-018-06801-1.

32.

Molecular characteristics of carbapenem-resistant Pseudomonas aeruginosa isolated from urine in Hyogo, Japan.

Osawa K, Shigemura K, Kitagawa K, Fukuda T, Takasaka A, Wakabayashi S, Sato K, Yamamichi F, Shirakawa T, Fujisawa M.

Int J Urol. 2019 Jan;26(1):127-133. doi: 10.1111/iju.13818. Epub 2018 Oct 11.

PMID:
30308701
33.

Predictive factors of improvement for voiding symptoms after holmium laser enucleation of the prostate.

Yamamichi F, Shigemura K, Kitagawa K, Fujisawa M.

Int J Urol. 2019 Jan;26(1):136-137. doi: 10.1111/iju.13825. Epub 2018 Oct 11. No abstract available.

PMID:
30308697
34.

Ovarian stromal cells as a source of cancer-associated fibroblasts in human epithelial ovarian cancer: A histopathological study.

Fujisawa M, Moh-Moh-Aung A, Zeng Z, Yoshimura T, Wani Y, Matsukawa A.

PLoS One. 2018 Oct 10;13(10):e0205494. doi: 10.1371/journal.pone.0205494. eCollection 2018.

35.

Serum DHEA-S Is a Predictive Parameter of Abiraterone Acetate in Patients with Castration-resistant Prostate Cancer.

Suzuki K, Sakamoto M, Terakawa T, Furukawa J, Harada K, Hinata N, Nakano Y, Fujisawa M.

Anticancer Res. 2018 Oct;38(10):5929-5935. doi: 10.21873/anticanres.12938.

PMID:
30275221
36.

Occurrence and characterization of carbapenem-resistant Gram-negative bacilli: A collaborative study of antibiotic-resistant bacteria between Indonesia and Japan.

Kuntaman K, Shigemura K, Osawa K, Kitagawa K, Sato K, Yamada N, Nishimoto K, Yamamichi F, Rahardjo D, Hadi U, Mertaniasih NM, Kinoshita S, Fujisawa M, Shirakawa T.

Int J Urol. 2018 Nov;25(11):966-972. doi: 10.1111/iju.13787. Epub 2018 Sep 25.

PMID:
30253445
37.

Cubane-Type [Mo3 S4 M] Clusters with First-Row Groups 4-10 Transition-Metal Halides Supported by C5 Me5 Ligands on Molybdenum.

Ohki Y, Uchida K, Hara R, Kachi M, Fujisawa M, Tada M, Sakai Y, Sameera WMC.

Chemistry. 2018 Nov 16;24(64):17138-17147. doi: 10.1002/chem.201804083. Epub 2018 Oct 31.

PMID:
30204282
38.

A Case-control Study on the Risk Factors for Ischemic Colitis.

Uchida T, Matsushima M, Orihashi Y, Dekiden-Monma M, Mizukami H, Nakahara F, Nakamura J, Fujisawa M, Koike J, Suzuki T, Mine T.

Tokai J Exp Clin Med. 2018 Sep 20;43(3):111-116.

39.

Computed Diffusion-Weighted Imaging in Prostate Cancer: Basics, Advantages, Cautions, and Future Prospects.

Ueno YR, Tamada T, Takahashi S, Tanaka U, Sofue K, Kanda T, Nogami M, Ohno Y, Hinata N, Fujisawa M, Murakami T.

Korean J Radiol. 2018 Sep-Oct;19(5):832-837. doi: 10.3348/kjr.2018.19.5.832. Epub 2018 Aug 6. Review.

40.

Comparison between non-septic and septic cases in stone-related obstructive acute pyelonephritis and risk factors for septic shock: A multi-center retrospective study.

Yamamichi F, Shigemura K, Kitagawa K, Fujisawa M.

J Infect Chemother. 2018 Nov;24(11):902-906. doi: 10.1016/j.jiac.2018.08.002. Epub 2018 Aug 30.

PMID:
30174285
41.

Acquisition of antimicrobial-resistant variants in repeated infections caused by Pseudomonas aeruginosa revealed by whole genome sequencing.

Nakanishi N, Nomoto R, Sato K, Koike C, Kusuki M, Nakamura T, Shigemura K, Shirakawa T, Fujisawa M, Tokimatsu I, Osawa K.

J Infect Chemother. 2019 Feb;25(2):154-156. doi: 10.1016/j.jiac.2018.07.016. Epub 2018 Aug 17.

PMID:
30126693
42.

Chromophobe renal cell carcinoma with sarcomatoid differentiation containing various heterologous components.

Hyodo T, Kanzawa M, Hara S, Takahashi K, Ogawa S, Furukawa J, Fujisawa M, Kobayashi A, Kuroda N, Itoh T.

Pathol Int. 2018 Sep;68(9):524-529. doi: 10.1111/pin.12704. Epub 2018 Jul 17.

PMID:
30015409
43.

Apoptosis and non-alcoholic fatty liver diseases.

Kanda T, Matsuoka S, Yamazaki M, Shibata T, Nirei K, Takahashi H, Kaneko T, Fujisawa M, Higuchi T, Nakamura H, Matsumoto N, Yamagami H, Ogawa M, Imazu H, Kuroda K, Moriyama M.

World J Gastroenterol. 2018 Jul 7;24(25):2661-2672. doi: 10.3748/wjg.v24.i25.2661. Review.

44.

Arterial stiffness, not systolic blood pressure, increases with age in native Papuan populations.

Ishida A, Fujisawa M, Del Saz EG, Okumiya K, Kimura Y, Manuaba IIB, Kareth MF, Rantetampang AL, Ohya Y, Matsubayashi K.

Hypertens Res. 2018 Jul;41(7):539-546. doi: 10.1038/s41440-018-0047-z. Epub 2018 May 14.

PMID:
29760461
45.

Association of the PCK2 Gene Polymorphism With New-onset Glucose Intolerance in Japanese Kidney Transplant Recipients.

Yokoyama N, Ishimura T, Oda T, Ogawa S, Yamamoto K, Fujisawa M.

Transplant Proc. 2018 May;50(4):1045-1049. doi: 10.1016/j.transproceed.2018.01.042.

PMID:
29731064
46.

Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.

Tokimatsu I, Shigemura K, Osawa K, Kinugawa S, Kitagawa K, Nakanishi N, Yoshida H, Arakawa S, Fujisawa M; Research Group of Japan Infection Prevention and Control Conference for National and Public University Hospitals.

J Infect Chemother. 2018 Aug;24(8):641-647. doi: 10.1016/j.jiac.2018.03.015.

PMID:
29685855
47.

Risk factors for death from Stenotrophomonas maltophilia bacteremia.

Osawa K, Shigemura K, Kitagawa K, Tokimatsu I, Fujisawa M.

J Infect Chemother. 2018 Aug;24(8):632-636. doi: 10.1016/j.jiac.2018.03.011. Epub 2018 Apr 16.

PMID:
29673561
48.

Prospective study of robotic partial nephrectomy for renal cancer in Japan: Comparison with a historical control undergoing laparoscopic partial nephrectomy.

Tanaka K, Teishima J, Takenaka A, Shiroki R, Kobayashi Y, Hattori K, Kanayama HO, Horie S, Yoshino Y, Fujisawa M.

Int J Urol. 2018 May;25(5):472-478. doi: 10.1111/iju.13544. Epub 2018 Apr 19.

49.

Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell Carcinoma.

Yamamoto K, Hara T, Nakagawa T, Hirai M, Miyake H, Fujisawa M, Yano I.

Target Oncol. 2018 Jun;13(3):371-378. doi: 10.1007/s11523-018-0563-4.

PMID:
29633072
50.

Presurgical pazopanib for renal cell carcinoma with inferior vena caval thrombus: a single-institution study.

Terakawa T, Hussein AA, Bando Y, Guru KA, Furukawa J, Shigemura K, Harada K, Hinata N, Nakano Y, Fujisawa M.

Anticancer Drugs. 2018 Jul;29(6):565-571. doi: 10.1097/CAD.0000000000000627.

PMID:
29629905

Supplemental Content

Loading ...
Support Center